We report an HPLC method for measuring the concentrations of reduced (GSH) and total (GSHt) free glutathione in human plasma and whole blood. The chromatographic step was coupled with a postcolumn derivatization reaction and fluorometric detection. The linear range was 0. 81-13.02 mol/L, and the detection limit was 0.13 mol/L.
France Michelet,' Ren#{233} Gueguen,' Pierre Leroy,2 Maria Wellman,3 Alain Nicolas,2 and Gerard Siest1'3' 4 We report an HPLC method for measuring the concentrations of reduced (GSH) and total (GSHt) free glutathione in human plasma and whole blood. The chromatographic step was coupled with a postcolumn derivatization reaction and fluorometric detection. The linear range was 0.81-13.02 mol/L, and the detection limit was 0.13 mol/L.
In healthy adults (ages 18-73 years), mean concentrations were 941 ± 155 mol/L for GSHt and 849 ± 63 mol/L for GSH in blood (107 men, 94 women), and 3.39 ± 1.04 mol/L for GSH in plasma (66 men, 58 women).
Blood GSHt but not GSH was significantly lower in children (32 boys, 32 girls: 872 ± 157 p.mol/L) than in adults. Blood GSHt and GSH appeared to be correlated positively with the number of cigarettes smoked per day and the regular practice of physical exercise, and negatively with alcohol abstinence. We observed positive correlations between blood GSHt and cholesterol and calcium concentrations, and between blood GSH and cholesterol concentration.
Indexing Terms: biological variation/y-glutamyltransferase/antioxidants/cholesterol/free radicals/sex-and age-related effects
The tripeptide glutathione (gamma-L-glutamyl-Lcysteinylglycine)
is the major intracellular nonprotein thiol compound and plays a major role in the protection of cells and tissue structures (1) . This tripeptide acts as a nucleophilic scavenger and as an enzyme-catalyzed antioxidant in electrophilicloxidative tissue injuries that arise from both endo-and exogenous sources. Intracellular and blood glutathione concentrations are in the millimolar range, whereas plasma concentrations are in the micromolar range. The tripeptide can be free (GSHt), reduced (GSH), oxidized (GSSG), or bound to proteins. 5 Glutathione allows the detoxification of free radicals and oxygen-reactive species involved in such diseases as atherosclerosis, rheumatoid arthritis, adult respiratory distress syndrome, or reoxygenation injury; consequently, its concentration decreases in such diseases (2) . A decrease in erythrocyte GSH content has been reported in patients affected by y-glutamylcysteine synthetase deficiency and hemolytic anemia (3) . Decreased hepatic GSH concentrations have been observed in alcoholic (4, 5) and nonalcoholic (4, 6) liver diseases.
Plasma GSHt concentrations also decrease in such diseases (7) . Clinical studies and laboratory investigations of patients infected by HIV suggest that this syndrome may be the consequence of a virus-induced cysteine deficiency that results in a decrease in glutathione in plasma (8, 9) , lung epithelial lining fluid (8) , mononuclear cells (9) , and T lymphocytes (10) . High glutathione concentrations, on the other hand, may be a disadvantage for cancer treatments, as glutathione is involved in some of the chemotherapy resistance processes (11, 12) .
In healthy subjects (13- 
Materials and Methods Subjects
The human population studied included 265 apparently healthy subjects, 139 males (107 adults, median age 40.0 ± 11.9, and 32 children, median age 13.5 ± were by integrator (Chromjet; Spectra-Physics).
Analytical Methods

Blood sample collection and treatment.
Venous blood samples (5-mL) were collected in EDTA-Vacutainer Tubes (Becton Dickinson, Grenoble, France) between 1145 and 1230, and blood was kept at room temperature before treatment. L-serine borate, 100 mmol/L (100 ML), was added within 15 ± 5 mm of blood collection. Then, 1 mL of blood was added to 0.5 mL of the perchloric acid solution and centrifuged at 10 000g for 3 mm at room temperature.
The resulting supernatant was frozen in liquid nitrogen and stored at -80 #{176}C before analysis (within 15 days). Plasma was obtained from the residual blood by centrifugation at 60g for 10 mm at 4 #{176}C. Then, within 25 ± 5 mm of blood collection, 1 mL of plasma was mixed with 0.5 mL of the perchloric acid solution. The same procedure as above was performed.
Before analysis, samples were thawed in a water bath at 37 #{176}C, and a 50-L aliquot was injected onto the column for GSH assay. Acidic supernatants from blood samples were usually diluted 100-fold in a solution of 0. 
Results
Validation of Sample Preparation
We initially determined that there was no significant difference in blood GSH and GSHt concentrations in samples that were treated with perchloric acid every 5 mm from 2 to 22 mm after blood collection. We determined GSH concentrations of 872 ± 11 mo1/L (n = 3) 2 mm after blood collection, and of 857 ± 19 moI/L (n = 3) after blood was stored for 22 mm at room temperature before perchioric acid addition. Respective GSHt concentrations (n = 3) were 1024 ± 17 mo1JL and 1051 ± 55 mol/L. Then we tested the evolution of plasma GSH over the same period. Similar plasma GSH concentrations were measured when blood was stored at room temperature for 2 or 22 mm before centrifugation; respective plasma GSH concentrations were 3.62 ± 0.04 moIJL and 3.89 ± 0.06 p.mol/L. We added a mixture of serine borate to blood before centriftigation to inhibit GGT activity during this step (31). In view of these results, we chose to treat blood samples at 15 (± 5) mm after blood collection to ensure good reproducibility and feasibility of sample treatment and accurate determination of both blood and plasma glutathione concentrations. Indeed, a shorter delay would be difficult to apply routinely.
Validation of HPLC Glutathione Assay
The HPLC assay previously developed in our laboratory (29) was validated to allow accurate glutathione determination both in plasma and whole blood. concentration was not affected by alcohol consumption (Tables 3 and 4) . Physical exercise. Practice of physical exercise was associated with increased blood GSHt and GSH concentrations (Table 4) , but with the difference being significant only for GSH (Table 3) . Moreover, there was a significant decrease of glutathione oxidation, as shown by the increase of the GSH/GSHt ratio, when subjects practiced regular physical exercise (Table 3) . Results did not reach statistical significance in plasma (Tables 3 and 4) .
Linearity range and limit of detection (LOD
Oral contraceptive use. There was a tendency towards decreased values among women who used oral contraceptives, but blood GSHt and GSH means were not significantly lower in this group (Tables 3 and 4 ).
GGT activity.
Our results did not show any correlation between GGT activity and glutathione concentra- (Tables 5  and 6 ). Moreover, we measured both blood and plasma glutathione concentrations from 148 individuals, whereas previous data concerned either blood or plasma glutathione concentrations. Another main point is that our samples come from a general population.
Our results showed that, both in whole blood and plasma, mean glutathione concentrations measured in men or women are not statistically different. This fact was previously reported by other workers for blood (13, 16, 19, 20) and plasma
(28).
Most of the results reported in Table 5 initially concerned erythrocytes instead of blood glutathione concentration.
We chose to measure whole-blood glutathione to minimize variability from sample preparation.
To compare our results with already published data, we recalculated these latter results by using the reference values for the number of erythrocytes or hemoglobin (g/L of blood) published by Dufer (36). We also note that results obtained in plasma (Table 6 ) are more scattered than in whole blood, probably because of the separation step required for preparing plasma samples. The difference between men and women for plasma GSH concentrations fluctuates between 5% (our results) and 28% (21).
Regarding aging, we observed the lowest blood and plasma glutathione concentrations in children, and no variation with aging in adults (Tables 1 and 2 ). The same pattern has been reported by other workers ( Consequently, we defined mean reference concentra tions for blood GSHt and GSH in an apparently health adult population without sex distinction (ages 18-7 years):respectively, 941 ± 155 moWL and 849 ± 16 j.tmol/L; reference plasma GSH concentration was 3.3 ± 1.04 moL/L.
In the youngest group (subjects age 10-17 years), glutathione concentrations were respec tively 872 ± 157 moI/L, 814 ± 171 molIL, and 3.57 0.74 moI/L.
Thus, we determined that plasma GS Our results result in a significant increase in GSH or GSHt con- 
